The British Veterinary Association has welcomed the tightening up of sales of veterinary medicines on the internet but has expressed disappointment that the advertising of antimicrobials to farmers will continue.
The Veterinary Medicines Directorate has today published its response to the public consultation on the Veterinary Medicines Regulations, which are updated every year.
The new Regulations, which come into force in April 2011, introduce new controls on internet pharmacies meaning that only approved websites will be legally allowed to dispense and supply veterinary medicines. The controls will come into force in April 2012 and the BVA supports the use of a logo on approved websites to help consumers buy medicines from reputable sources.
The BVA has previously expressed concern that pet owners could inadvertently buy counterfeit veterinary medicines online and urges veterinary clients to seek advice from their vet and only buy from UK-based companies.
Harvey Locke, President of the BVA, said: "Without proper regulation online pharmacies could be sourcing drugs from overseas and selling counterfeit medicines that look genuine to unsuspecting pet owners. These medicines are placebos at best and dangerous at worst.
"We therefore welcome the VMD's decision to clampdown on irresponsible online retailers and provide a clear logo for approved websites that will give pet owners confidence.
"We have also asked the VMD to put a stop to the increasing problem of prescription fraud and we hope the tighter regulation announced today will be a step towards achieving that aim.
"However, we would urge all pet owners to continue talking to their vet about sourcing medicines from the internet to make sure the right drugs are bought and administered correctly."
In light of increasing concerns about the growth of antimicrobial resistance the VMD's consultation canvassed views on restricting the advertising of antimicrobials to farmers. The BVA says it supported a ban on advertising as a sensible approach to the responsible use of antimicrobials, and is disappointed that the VMD has decided not to go ahead with it. Mr Locke said: "New antimicrobials are heavily advertised by pharmaceutical companies to vets and farmers so it is vital that the message of responsible use is not lost.
"Antimicrobial resistance is a serious issue for both animal and human health and we are disappointed that the VMD is not restricting the advertising of these products to farmers. The pharmaceutical companies must now undertake to advertise responsibly.
"Ultimately, it is the veterinary surgeon who will make the decision on which veterinary products to use and vets and farmers should work together to ensure antimicrobials are used prudently and responsibly."
Companion Care has opened its 80th surgery, within the Ilford Pets at Home store.
Companion Care Vets managing director, Jane Balmain said: "The opening of our 80th surgery proves the success of our joint venture partner business model. At present the majority of our surgeries are located inside Pets at Home stores but we also have four very successful standalone surgeries. Our standalone surgery network is now being developed to create further exciting opportunities for future growth, with our first new standalone surgery opening in Scotland this December."
Joint venture partner and veterinary surgeon at Companion Care Vets Ilford Alberto Arciniega said: "Alongside the fantastic team we have on board, my partners Nick and Claire and I are extremely proud to be opening our second surgery here in Ilford. Having been partners at the Romford surgery since July 2009 we have seen the company grow consistently and successfully. We feel honoured to be opening the groups' 80th surgery and look forward to the challenge of managing both practices and to delivering outstanding veterinary care."
With 102 Joint Veterinary Partners, 83 of whom are veterinary surgeons, 12 veterinary nurses, 6 practice managers and 1 receptionist and a further 789 staff employed by the group Companion Care Vets is one of the largest veterinary employers in the UK. Dividend payments to joint venture partners in the 2010/2011 period totalled £2.181 million and the group says it plans to open a further 10 surgeries across the UK before the end of year.
Merial Animal Health has announced the launch of its new feline vaccine Purevax Rabies in the UK and Ireland.
Merial says the product offers a simple but elegant solution to rabies vaccination, without the need for adjuvant. According to the company, the non-replicative vector is processed by the cat's immune system in the same way as a live virus, triggering both a powerful cell mediated and humoral response without the need for adjuvant. However, because the vector cannot replicate effectively in mammalian cells, there is no risk of any reversion to virulence.
Merial's Veterinary Technical Manager Kevin Whelan, said: "This is a perfect complement to our existing range of advanced technology vaccines, which already offer the benefits of highly effective protection, including updated FCV strains, without the need for adjuvant. It also represents Merial's continued commitment to the development of innovative products for the animal health market".
The vaccine is licensed for use in cats from 12 weeks of age, and administration of a single injection has been shown to provide protection against disease.
Contact your local Merial Representative or the Merial Technical Support line on 0870 6000 123 for further information.
Given the improbability of anyone being alerted by a goldfish: "blub-blub-behind-blub-you-blub-blub-the-blub-frying-blub-blub-pan-is-blub-on-fire-blub", one has to presume the respondents were talking about dogs.
But no, according to npower, 10% of the participants in its survey reported that their cat or dog had directly saved their life, or the life of someone they know.
Really? Saved by a cat? I should have thought a cat would be more likely to turn on it's heels and strut out of the room nonchalantly.
Still, the point of the npower's research was to highlight the dangers of carbon monoxide. In its press release, the company pointed out that pets can suffer CO poisoning symptoms of vomiting, tiredness and erratic behaviour before people.
So perhaps that's what the cat owners meant when they'd been saved by the cat: like a miner would say they were saved by a canary.
Norbrook Laboratories has launched Norfenicol Solution for Injection (florfenicol), a broad spectrum antibiotic licensed for the treatment of pneumonia in cattle and pigs.
Dr Barry McInerney, Norbrook's GB Veterinary Advisor said: "With many farmers preparing for winter housing, the launch of Norfenicol is timely as pneumonia represents the most common disease of housed cattle in the UK costing the agricultural industry an estimated £80m per year. Norfenicol is an easy to inject, cost effective treatment of pneumonia which kills bacteria quickly, and is available in a durable plastic bottle. Studies have shown florfenicol, the active ingredient in Norfenicol, to have a high bacteriological and clinical efficacy (100% and 96% respectively) against susceptible bacteria in the treatment of calf respiratory tract diseases."
Norfenicol is indicated for the treatment of bacterial respiratory disease in cattle associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somniand for the treatment of acute outbreaks of respiratory disease caused by strains of Actinobacillus pleuropneumoniae, and Pasteurella multocida in swine.
Dr McInerney added: "NSAIDs have also been shown to be a beneficial ancillary therapy in treating bacterial pneumonia, to alleviate pain as well as to reduce inflammation and pyrexia. Norbrook has a range of NSAID products which are available as an adjunctive treatment for pneumonia in cattle, including Loxicom 20 mg/ml solution for injection for cattle, pigs and horses."
For further product information, visit www.norbrook.com
The 2016 PAW Report, in which 4252 dog, cat and rabbit owners were surveyed by YouGov, found that 24% (an estimated 5.2M) of owners did no research at all before buying a pet.
Only 5% of prospective owners spoke with a veterinary professional before buying an animal.
This raises the question of whether practices could be doing more to engage with prospective pet owners, by offering free or low-cost pre-purchase consultations with a veterinary nurse which offer advice about suitable pets and breeds to fit with the buyer's lifestyle.
The PAW Report also discovered that 65% of prospective pet owners were unaware of the five welfare needs. Many also dramatically underestimate the financial implications of owning a pet with 12% of owners believing their pet would only cost up to £500 over their entire lifetime. Overall, 98% of respondents underestimated the lifetime cost of owning their pet to some degree.
Buying pets from inappropriate sources was another major concern, with 23% of veterinary professionals identifying this as one of most critical issues which they would choose to resolve tomorrow. 50% of owners said they would consider getting a pet from a private, classified online advert. 18% of owners said they would still consider getting a puppy from a puppy farm, while others would consider getting a pet from an advert posted on social media (37%), from a pet supermarket (41%), or a pet that has been imported from abroad (28%).
A pre-purchase consultation could help address all of these issues, helping to set the owner's expectations about costs, educate them about the five welfare needs and steer them in the direction of reputable source to buy their new pet.
Such consultations would obviously need to be marketed beyond existing clients in the waiting room, but could be added to existing marketing materials used in the local media and added to the practice website ('Thinking of buying a pet, talk to us first').
To help practices that want to engage with potential pet owners in this way, the PDSA has launched a free ‘Which Pet?’ consultation framework for veterinary teams. The materials include client and explanatory vet team booklets, marketing materials and an e-learning CPD module. They can all be accessed free of charge on PDSA’s website at: pdsa.org.uk/whichpet
Commenting on the PAW Report findings, Sean Wensley, PDSA senior veterinary surgeon, said: "There is little doubt that we’re a nation of animal-lovers. But the PAW Report highlights that impulse-buying pets is still an issue of great concern, and shows no signs of improving. Little or no research before getting a pet means owners have limited understanding of what their pets require throughout their lives, which is undoubtedly leading to an array of other troubling pet welfare problems."
Other key findings:
Vets Now launched the service at the start of the pandemic to provide remote veterinary advice, and it has now expanded from eight to nearly 30 emergency vets.
In 2022, Video Vets Now had over 13,000 consultations, with 80% of these occurring out-of-hours. Sundays are the busiest day, with almost a third of all consultations taking place.
Of these total consultations, 17% of pets were discharged normally, 7% were immediately referred in-clinic, and 48% were discharged as non-emergency cases, but with a recommendation to get a daytime vet appointment within 48 hours.
Dave Leicester, Vets Now’s head of telehealth says the fact that so few of Video Vets Now calls are referred on to a face-to-face consultation is a real benefit for pet owners and the veterinary profession: “Over two thirds of cases don’t need to be seen urgently by a vet.
"A lot of the cases are pet owners needing some clinical reassurance.
"As cases are triaged remotely, the service therefore frees up clinical staff for genuine emergencies.
“Additionally, without the service, many clients would have no other option than to attend for a full consultation at an out-of-hours clinic; so, clients save money too, allowing them to save their budget to spend at their daytime practices.
“Following the triage consultation, if the pet does need a non-urgent face-to-face consultation, we always direct clients to their registered vet. The £24 Video Vets Now consultation fee is then refunded.
"We call this our ‘Never Pay Twice’ promise, and it applies regardless of where that follow on consultation takes place.
"We see this as a win-win situation for clients and practices.”
Dave continued: “Over the past three years, Video Vets Now has seen unparalleled growth, providing essential care and reassurance for pet owners during a time of many challenges to traditional veterinary practice.
“As the pandemic has drawn to a close, we have consolidated our position as one of the UK's foremost providers of teletriage.
"Looking to the future, the changes in veterinary regulation will allow us to grow further and expand the range of services we can provide, bringing telehealth to an even greater number of pet owners.”
The 2,200sqm building – equivalent to half a hockey pitch or four netball courts – will include a range of facilities across two floors. It will have two new lecture theatres, a number of IT-rich teaching and learning spaces, general teaching rooms and various environments for teaching clinical skills.
The University’s Vice-Chancellor, Dr David Llewellyn, said: "Our plans for the Veterinary School are proceeding well, with our first student intake to the new veterinary medicine course due in 2020.
"The building on the Harper Adams site will provide a great range of teaching facilities for our students, to complement the wide range of animal facilities we already have on campus. We are excited to see the progress that is being made with the Harper & Keele Veterinary School, which is generating considerable interest within the veterinary profession, and we look forward to seeing the new building take shape in the coming months."
Picture shows: Vice Chancellor Dr David Llewellyn, McPhillips’ Marketing Manager Mark Kiddie, Site Manager Ed Bickford, McPhillips’ Managing Director Paul Inions, Head of Estates and Facilities at Harper Adams University, Jonathan Cain,
Ceva Animal Health has extended its Meloxidyl dogs and cats’ range with the launch of a new 5ml Meloxidyl oral suspension for cats.
The company says the new bottle size will provide more prescription options for veterinary practices currently stocking 15ml bottles and is a perfect post-surgery size to send patients home with. The bottles are also clear brown in colour; designed to make it easier for cat owners to see how much liquid is left in each bottle.
Meloxidyl oral suspension for cats contains meloxicam for the alleviation of pain and inflammation. It is licensed for the treatment of musculo-skeletal disorders and the alleviation of post-operative pain.
Rob McLintock, business unit manager at Ceva Animal Health said: "The new 5ml Meloxidyl oral suspension for cats’ bottle will provide veterinary practices with more prescription options for the management and alleviation of pain and inflammation in cats."
To support the launch of the new 5ml Meloxidyl presentation, Ceva is running a competition to win one of five BSAVA Manuals of Anaesthesia and Analgesia by answering one question: ‘How many millilitres are in the new Meloxidyl cat bottle’?
To enter the competition, email analgesics-group@ceva.com. Include ‘Meloxidyl competition’ in the subject line and contact details and the answer to the question in the main body of the email.
For further information on Ceva’s analgesic product range, contact your local Ceva territory manager, email analgesics-group@ceva.com or call 01494 781510.
Published by CABI and sponsored by Mars Petcare UK, Companion Animal Economics was developed by Daniel Mills, Professor of Veterinary Behavioural Medicine at the University of Lincoln, and Dr Sandra McCune, Human-Animal Interaction expert at Mars Petcare’s WALTHAM Centre for Pet Nutrition. It documents and examines available evidence on the direct and indirect benefits and costs of companion animals to society, including their influence on human mental and physical health, illness prevention and well-being.
Other authors include Dr Sophie Hall from the University of Lincoln’s School of Life Sciences, Professor Ted Fuller and Luke Dolling from the Lincoln International Business School, and Katie Bristow-Wade of Dogs for Good.
Professor Mills said: "Vets are well aware how important companion animals are to their owners, but it is important that they appreciate the positive impact that they can have on the physical, mental and social health of both individuals and society more widely. This book should help raise awareness of this and their economic importance in times of economic uncertainty."
Dr McCune said: "Almost half of households in the UK share their homes with animals cared for as companions – a relationship we consider to be valuable and enriching. At Mars Petcare, we’re committed to creating A BETTER WORLD FOR PETS™. That’s because we know that pets make our world better. This important report provides a modern day update on the impact of companion animals on the UK economy and society, without reducing the discussion to a simplistic cost-benefits ratio. Critically, it aims to raise awareness of the need for research to evaluate the complex routes by which pets make an economic impact on UK society."
The author says relatively little information on the economic impact of pets has been published since the 1988 seminal Council for Science and Society (CSS) report on Companion Animals in Society, which inspired Companion Animal Economics. Since then, trends in pet ownership and associated industries, have changed a great deal. The report’s methodology sought to capture this new context, including issues like pet tourism, pet obesity, and expanding veterinary services, identifying clear gaps where further high-quality data and additional research are needed.
When evaluating the contribution of companion animals to the UK economy, both positive and negative aspects were considered. The cost of NHS treatment for bites and strikes from dogs is estimated at £3 million per year. At the same time, the report also estimates that pet ownership in the UK may reduce use of the UK health service by up to £2.45 billion per year. This conservative conclusion is drawn through examining healthcare savings through reduced number of doctor visits.
Given the scale of the potential impact, the report concludes that research into companion animals and their economic impact on society needs further investigation and should be supported by government. While UK data were used in the report, many of the points raised relate to other industrialised nations, demonstrating the global nature of this issue.
The Strategic Plan was developed throughout the course of 2016 with input from a number of stakeholders including RCVS Council and Veterinary Nurses Council, key committees and College staff. Most importantly, the evidence for change came from the wide and deep consultations that took place within Vet Futures, the joint RCVS and British Veterinary Association project that aims to help the veterinary profession prepare for and shape its future.
The other four ambitions described in the plan are:
Nick Stace, RCVS CEO, said: "The hallmark of our 2014 to 2016 Strategic Plan was getting the basics right by clarifying our identity, improving our core functions, setting out our service agenda and strengthening our foundations. The plan gave us a firm foundation to build upon and improved levels of confidence in the College from stakeholders which has allowed us to be more ambitious and outward-looking with this new plan.
"Within the new plan there are challenging ambitions and stretching objectives that address some of the big issues affecting the veterinary team, whether that’s playing a more global role post-Brexit, the importance of embracing new technology, or the pressing need to consider culture change within the profession to ensure it continues to grow and learn.
"I would ask each member of the profession to take a look at the Strategic Plan and I am very happy to receive comments and feedback on the plan by email at nick@rcvs.org.uk."
To download the Strategic Plan, visit www.rcvs.org.uk/publications
The Vet Channel has launched VetPod, a customisable video display system for practice waiting rooms.
The VetPod system is comprised of three elements: a website where you select the media you want to display in your waiting room, the VetPod, which downloads the videos you select, and a monitor on which to display them in your waiting room.
The Vet Channel says it is updating its media library regularly, so you can pick content which ties in with your practices' clinical focus, marketing strategy and promotional offerings.
The system also allows you to upload your own logos, photographs and videos, and display practice specific information, such as staff news, opening hours, special clinics and promotions. In addition The Vet Channel's in-house design studio can create bold, eye-catching media content to reflect your brand and promote every aspect of your services.
Anthony Beliovich from Companion Care said: "Enquiries about microchipping and flea treatment increased by 25% after we installed The Vet Channel."
For more information, visit http://www.thevetchannel.co.uk/, email enquiries@thevetchannel.co.uk, or ring: 0844 8111406
Alternatively, you'll be able to see a demonstration of VetPod at BSAVA Congress this year.
MSD says the new license claim means the vaccine combines the broadest calf scour protection available with unique user convenience.
MSD Animal Health livestock veterinary adviser Dr Kat Baxter-Smith said: “When correctly administered as a single 2ml intramuscular dose to pregnant cattle 12-3 weeks prior to calving, Bovilis Rotavec Corona boosts antibodies in colostrum for rotavirus, coronavirus and now both E.coli F5 (K99) and F41.
"Calves gain protection against these infectious scour pathogens by drinking the fortified colostrum from their vaccinated mothers.
“Bovilis Rotavec Corona also contains the most prevalent rotavirus strain in Europe2, which minimises the chances of a calf scour protection breakdown due to differences between vaccine antigens and the ubiquitous antigens on farm3.”
Kat added: "Vet, RAMA and farmer feedback suggests the wide vaccination window (12-3 weeks pre-calving) and the fact that an opened bottle of vaccine lasts for up to 28 days are particularly useful practical benefits in a mix of both dairy and beef suckler systems.”
Bovilis Rotavec Corona is available in 5, 20 and 50-dose packs from both veterinary professionals and the agricultural merchant trade.
References
Current estimates suggest that around 95,000 calves, 30 million chicks and 3,000 Billy kids are affected per year.
The new position calls for solutions based on the overarching principle that quality of life should take precedence over lifespan, with the longer-term aim to move away from the production of unwanted animals all together. In the meantime, the position calls for further research into solutions to reduce numbers of additional male offspring and for humane methods of killing surplus animals on-farm.
The dairy and egg industries have been advised to adopt a ‘3Rs’ (reduce, replace, refine) approach to the rearing and slaughter of animals which are surplus to the requirements of the specific industries. Reduction recommendations include selecting for sex (a technology used quite frequently within the dairy farming community) and increasing the length of time that an animal can produce milk through selective breeding.
In the absence of these options, the position recommends raising male offspring for meat, with the caveat that calves and billy goat kids should be raised within UK high welfare schemes only.
In the absence of any reduce or replacement options, veterinary experts advise that killing should be undertaken in the most humane way and that all the animal’s welfare needs must be addressed prior to slaughter.
In line with BVA’s sustainable animal agriculture position, this policy recommends that when animals are killed, every effort should be made to make sure that the carcass is used. For example, the carcasses of male chicks killed by controlled atmospheric stunning can be used in animal feed, such as for reptiles and birds of prey.
BVA Junior Vice President, James Russell (pictured right) said: "Unwanted male production animals in the dairy and meat industries are an ethical challenge on a number of levels. Firstly, for the producer who may have animals with little or no commercial value. Secondly, for the consumer who may find the notion of these unused animals a difficulty. Our new joint position is based around the principle of ‘a life worth living’ and looks at ways that the veterinary profession can work with the farming community to reduce the numbers of animals that this affects and ensure that high welfare is always front and centre.
"If slaughter of affected animals is undertaken humanely, it is not a welfare harm per se, but greater measures should be taken to make sure that these decisions are made with minimal carcass wastage and an eye to the economic, emotional and environmental impact at a farm level.
"With greater public understanding of ethical and animal welfare issues faced by the industry, the promotion of farm assurance schemes and further research into alternative breeding options such as selective sex technology, we hope to reduce these numbers and improve the welfare of the animals involved."
BCVA President, Professor David Barrett said: "The number of unwanted male dairy calves has fallen substantially in recent years, due in part to more efficient milk production meaning we now need fewer dairy cows to produce the same volume of milk, as well as the use of breeding technologies that mean we can select for female calves. Nevertheless, surplus males are still produced. Provided these calves’ welfare is protected they should become part of the meat production supply chain either as high-quality UK farm assured veal or beef."
"As we strive for improved sustainability and increase efficient use of resource in food production, we need to use every product from dairying, including calves that can be reared for meat. Our entire industry needs to work together to create a robust supply chains for high quality, farm assured British dairy beef and veal and we need to help consumers understand they should embrace these products. They are very different from intensively reared veal of the type produced in systems previously banned in the UK."
The RCVS is seeking feedback on a new draft Code of Professional Conduct.
The new Code, which would replace the existing RCVS Guide to Professional Conduct for Veterinary Surgeons, has been produced by a Working Party set up by the RCVS Advisory Committee to review the Guides for both veterinary surgeons and veterinary nurses.
According to the College, the purpose of the review, which last took place over a decade ago, is to ensure guidance to the profession and the public is clear. For example, using consistent language to distinguish between what must be done and what is advised.
The RCVS says the new Code is a short, principles-based document using the Federation of Veterinarians of Europe's Code of Conduct as the starting point. It will be supported by additional advice on specific areas of veterinary practice or issues, for example, clinical governance. It also includes:
Clare Tapsfield-Wright, Chairman of the Guides Review Working Party said: "Over the decade or so since it was last reviewed, not only has the Guide become unwieldy in places, but the way that regulators in general publish professional conduct rules has changed. Our draft new Code aims to clarify matters and bring us into line with best practice elsewhere.
"Animal owners are increasingly keen to understand the basis of what the veterinary profession considers to be good professional conduct. The new simplified Code should assist with this understanding."
The new Code, together with the consultation paper, can be downloaded at http://www.rcvs.org.uk/codeconsultation
Comments, which are welcomed from the profession and the public, should be sent by email to Christopher Murdoch, Secretary to the Guides Review Working Party, at c.murdoch@rcvs.org.uk by Friday, 24 June 2011.
A separate document is under development for veterinary nurses, which will share broadly similar underlying principles and will be the subject of its own consultation.
The company's new van has a range of 146 miles before it needs recharging, and it can be recharged to 80% within 40 minutes.
That puts 60% of MWI's customers within range of its distribution centre in Stoke-on-Trent, including those in Manchester and Birmingham.
As part of its drive to establish more sustainable operations, MWI has also launched a pilot with one of its corporate customers in which they reduce the number of deliveries made per week – adopting a two or three-day a week delivery system.
The company says that since January, that has resulted in 700,000 fewer vehicle miles.
Vetoquinol has announced the launch of its new support package to help vets and owners manage canine epilepsy with Epiphen, the company's phenobarbital medication.
Each Epiphen support package contains:
Accurate information is vital to help control epilepsy patients and the Owner Record Manual will enable owners to keep on top of this information. It contains charts to monitor seizure frequency and patterns, medication changes, blood test results and seizure characteristics.
The new "ask the expert" scheme offers vets the opportunity to ask for advice on epilepsy cases. Email epiphen@vetoquinol.co.uk with the query (and your contact details) and you will be put in touch with a neurology expert at a leading referral centre. Vets can also contact the Technical Helpline on 0800 1698197.
The Seizure Reports for vets provide a much more detailed tool for use at initial presentation or for owners to fill in when seizures differ in character. There is a pad of 30 tear-off sheets in each Epiphen support package.
Simon Boulton, Epiphen product manager said: "We understand that epilepsy is an emotional condition and wanted to provide vets and owners with more than just a tablet. I am convinced that with the Epiphen Support Package we are providing them with the tools they need to make the most of epilepsy management."
Epiphen also offers a free phenobarbital monitoring service. There is a voucher in each 30mg pack and 2 in each 60mg pack.
For more details on the Epiphen Support Package, to obtain a free practice starter pack or get extra copies of materials, please contact Vetoquinol on 0800 1608197 or contact your Vetoquinol representative.
The International Society of Feline Medicine (ISFM), the veterinary division of International Cat Care, has published Consensus Guidelines on the Practical Management of Diabetes Mellitus in Cats to help veterinary teams deliver optimal management for the diabetic cats presented in practice.
The guidelines were produced by an expert panel of veterinary clinicians and academics who reviewed clinical research studies to collate the best available evidence. They've been published in the March 2015 issue of the Journal of Feline Medicine and Surgery (JFMS) and are available to download free from http://jfm.sagepub.com/content/17/3/235.full.pdf+html.
The guidelines focus on the most important aspects of managing diabetic cats including weight control, use of an appropriate diet, insulin therapy (highlighting the value of longer acting insulin preparations) and close monitoring of blood glucose concentrations (including in the home environment).
The ISFM says the guidelines recognise that good diabetic control requires a long-term commitment and one of the keys to success is finding a treatment protocol that best fits in with owners' daily lives. Furthermore, owners may give up on treatment, or even elect for euthanasia of the cat, if the disease impacts too negatively on them and their relationship with their cat. However, with appropriate support and guidance from their veterinary practice, an owner can play an invaluable role in managing diabetes. A well-regulated cat will have a better prognosis and may also be more likely to go into diabetic remission, no longer requiring ongoing insulin therapy.
Among the resources available to assist owners of diabetic cats is a series of short videos produced by International Cat Care (available at http://www.youtube.com/iCatCare) demonstrating blood glucose sampling, insulin injection, and urine collection and testing.
Reference
The study, which was carried out by the VetCompass programme at the RVC, in partnership with Vets Now, also found that cats are most likely to be involved in a traffic accident in the autumn.
1,407 cat road traffic accident cases that attended Vets Now clinics across the UK between December 2011 and February 2014 were analysed, with researchers finding:
Younger cats, aged six months to six years, are at the greatest risk of road traffic accidents.
Male cats are 1.3 times more at risk of road traffic accidents than female cats.
Crossbred cats are 1.9 times more at risk of road traffic accidents compared to purebred cats.
Cats are more likely to be involved in a road traffic accident in the autumn. However, they are less at risk in winter as compared to spring.
Those cats that present with abdominal or spinal injuries are more likely to die, as are those that present with an increasing count of injuries.
RVC veterinary epidemiologist and VetCompass researcher Dr Dan O’Neill said: "One of the scariest times for any cat-owner is when they first start to let their cat go outside unattended. Owners of younger, and especially male, cats need to be especially vigilant. These results help owners to understand the true risks and therefore assist these owners to make the best decisions about if and how they let their cats go outside."
Dr Amanda Boag, Clinical Director of Vets Now, said: "We are very proud to have worked with VetCompass to ensure this important information about risks to our pet cats is made available to vets and the public. Working with our partners such as the RVC, we are committed to ensuring our large clinical database is used to help advance veterinary knowledge and understanding of emergency and critical care practice."
The full paper entitled 'Epidemiology of Road Traffic Accidents in Cats attending emergency-care practices in the UK' is published in the Journal of Small Animal Practice.
Faecal matter transplantation (FMT) has been used in people to treat Clostridium difficile infections and has also been trialled in conditions such as irritable bowel syndrome, Crohn’s disease and ulcerative colitis.
The researchers believe that FMT offers a potential new option for the treatment of chronic diarrhoea in dogs and the study will investigate whether it contributes to a more rapid resolution of clinical signs. The study is being conducted in association with eight other private practices or universities around the country.
Julien Bazelle, a European Veterinary Specialist in Small Animal Internal Medicine at Davies said: "The goal is to recruit, over a short period of time, canine patients with chronic small intestinal diarrhoea, for a randomised trial in which the cohort receives or not FMT at the time of the initial investigations and prior to any other treatment.”
Dogs aged 6 months to 10 years with a history of chronic small intestinal diarrhoea (+/- other GI signs) are needed to participate in the study. Half of the dogs will receive FMT and the other half will be managed without. FMT will be performed in eligible patients during the sedation for their routine abdominal ultrasound. Transplanted faecal matter will be administered via a retention enema.
To be eligible, dogs must not have received antibiotics, probiotics or steroids recently.
If you have a potentially suitable patient please contact: julien.bazelle@vetspecialists.co.uk or Fergus.Allerton@willows.uk.net
Jurox says the reformulation will also help reduce waste associated with unpreserved ampule formulations and will help streamline portfolios with a requirement for only one buprenorphine listing.
Dr Dan Cripwell BSc (Hons) BVSc CertAVP (EM) CertAVP PgCert (VPS) MRCVS, Advanced Veterinary Practitioner and senior veterinary technical advisor at Jurox (UK) Limited, said: “I am delighted that Jurox can provide the UK veterinary market with this evolution of our multidose buprenorphine formulation. We constantly strive to provide the veterinary profession with first class clinical and technical support and our ability to perform in-house product research and development is also a great strength; this allows us to remain agile enough to make adaptations in an area where not much has changed in the past few years.
“In this instance, we were able to examine what improvements could be made to our existing drug portfolio and respond to the profession’s feedback with the redevelopment of the commonly utilised opioid analgesic, buprenorphine. Our hope is that, as well as the recent mixing claims added to the product licence, this development will encourage the best clinical use of the drug and, in turn, improve patient experience and outcome.”
For more information, contact your local Jurox account manager, phone 0800 500 3171, visit www.jurox.com/uk or email customerservice@jurox.co.uk.
The Royal Veterinary College has launched an appeal to the veterinary profession to raise a target of £10,000 to enable VetAid Kenya to help during what has become the worst drought in living memory in the Horn of Africa.
According to the RVC, the drought has already forced over one million cattle and small stock south into the Tana Delta district of Kenya in search of grazing. Crowded together, these weakened animals are at major risk of infectious and parasitic disease. In some cases 80-90% mortality can be expected in herds or flocks. Without veterinary intervention, breeding livestock for communities in the Horn of Africa drought area will be devastated.
Government veterinary services are stretched and they are assisted in a coordinated response involving Vétérinaires Sans Frontières (Belgium, Switzerland and Germany) and VetAid Kenya which has staff in the field protecting herds. The programme has been partly funded by the Food and Agriculture Organisation (FAO), but with funds running low this vital activity is at risk just as it is most needed. VetAid Kenya is now the only veterinary agency working in the area, implementing an emergency vaccination programme to protect the breeding stock.
Gabriel Turasha, Director of VetAid Kenya said: "We only have one team working in Tana River and desperately need funds to send out three more teams as soon as possible. £10,000 would cover the cost of three teams, transport and vaccinations to treat 20,000 animals per week. This will make a real difference as we are providing the only veterinary support in this vast area.
"Our vaccination teams are ready to go out into the field at a few days notice. We just need to mobilize them. This is where the UK veterinary profession can help - every pound donated will make a huge difference!"
RVC Principal Professor Stuart Reid said: "Veterinary services are seriously stretched in Kenya and the only organisations with the flexibility, initiative and expertise to respond this to emergency are the veterinary NGOs such as VetAid Kenya and its Vétérinaires Sans Frontières partners.
"FAO has limited budget to spend on disaster response and RVC has a longstanding relationship with VetAid Kenya and with the region in general. As a College, we strongly feel that we should do all we can to support pastoral farmers in the region, and mounting this appeal is one way in which we can respond to the ongoing disaster and support our veterinary colleagues in East Africa."
The RVC and all other agencies involved in this appeal are contributing their services pro-bono so that all funds raised will go to the programme to help the people and animals struggling with the drought.
To donate, visit: www.rvc.ac.uk/vetaidkenya
The draw, which is open to UK mainland veterinary practices, can be entered here until 31st January 2018.
Fiona Sturgess, Vetlab's Sales and Marketing Manager, said: “The CombiSpin is designed for centrifuging relatively small volumes of biological liquids. It’s also very quiet, making it ideally suited for veterinary practice laboratories.
“So whether you’re entering on your own behalf as a practice owner, or to win one for your boss, it’s a great prize to win, and your chances are a lot better than with the National Lottery!"
Everyone who enters the draw (apart from the winner, of course), will be given 20% off the price of a new CombiSpin for their practice, valid to the end of the year.
More information about the CombiSpin is available here: http://vetlabsupplies.co.uk/products/combispin-veterinary-centrifuge/
The company says it's not just older horses suffering from joint disease, 36% of horses developed the condition by the time they were eight years old.
In the survey, 69% of horses needed up to five visits to their veterinary surgeon for treatment, while 21% needed as many as ten visits. Horse owners spent an average of £2,104 treating their horse’s joint condition while 5% spent more than £7,500 on the problem.
In addition, 53% said they've missed up to ten competitions due to joint disease, with 17% missing more than 20 competitions.
The survey revealed that joint problems are an ongoing concern for many. 76% of owners said they worry about their horse developing osteoarthritis and 30% had retired a horse earlier than expected owing to joint disease. In addition, 84% admitted that they would not buy a horse if they knew it had joint problems.
In terms of joint care, 74% of respondents said they give their horse a joint supplement. 69% check their horse's legs daily and 90% implement post-competition leg care measures.
Cavalor’s Lieselot Hamerlinck said: "It is good to see that so many horse owners are using a joint supplement but it’s important that they understand what to look for when choosing which product to use. They should look for anti-inflammatory products, not just joint support and for clinical evidence on any product claims. It’s not just about giving a joint supplement every day, it’s more about giving the right product tailored to the horse’s individual needs.
"Also horse owners should be mindful that it is equally important, if not more so, to take proper care of their horse’s joints all year round, not just during competition."
For further information, visit www.cavalor.com.
Mr Wilson faced two charges. The first was that in October 2017, he provided inaccurate information to an insurer in respect of a Labrador he treated by saying that the dog was presented to him with a lame left foreleg on 13 June 2017, when in fact the dog was presented for treatment on 7 June 2017 and that his conduct was therefore dishonest and misleading.
The second charge was that between 17 January 2017 and 17 January 2018 he failed to have any arrangements in place for Professional Indemnity Insurance (a requirement of the Code of Professional Conduct) and then, that between 8 January and 5 December 2019, he failed to respond to reasonable requests from the RCVS regarding his Professional Indemnity Insurance.
Prior to the hearing, Mr Wilson made an application to the Committee to adjourn the hearing subject to the Committee accepting his undertakings to remove himself from the Register and never to apply to be restored.
Mr Wilson’s legal representative at the hearing submitted to the Disciplinary Committee that granting the application would be in the public interest on the basis that Mr Wilson was 68 years of age and had now retired from the profession and closed his practice, that he had dedicated his entire working life to veterinary practice, had a previously long and unblemished career with no other complaints, and that he was well-regarded by clients and professional colleagues.
The application was not opposed by the RCVS whose representative informed the Committee that, relating to the charge of dishonesty, the College had taken into account that the insurance claim form was not submitted by Mr Wilson himself, and that there is no evidence of any financial motivation behind the charge nor any allegation of harm to an animal.
Taking into account the submissions from Mr Wilson’s representatives and from the RCVS, as well as precedent cases for such applications, the Committee decided that Mr Wilson’s voluntary undertakings went well beyond any sanction that could be imposed by the Committee and considered that the application would protect the public interest, confidence in the profession, and the welfare of animals.
Professor Alistair Barr FRCVS, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee decided that this is not a case in which the public interest or the welfare of animals demands that there be a full hearing, with determinations made by the Disciplinary Committee. Taking into account proportionality, and weighing in the balance the public interest, the interests of justice, the need to protect the welfare of animals, as well as the interests of both parties, the Committee decided to accede to the respondent’s application.”
The full findings of the Disciplinary Committee can be found at www.rcvs.org.uk/disciplinary